Concepedia

Author

Ting‐Rong Hsu

Taipei Veterans General HospitalORCID

Also Known As

Hsu T., T. Hsu, T.-R. Hsu, Ting Rong Hsu, Ting-Rong Hsu, TingRong Hsu, Ting‐Rong Hsu

88

Publications

1.3K

Citations

20

H-Index

71

Concepts

All Affiliations

Taipei Veterans General HospitalNational Yang Ming Chiao Tung UniversityNational Yang Ming University HospitalMackay Memorial Hospital
TH

About

Ting‐Rong Hsu is an author at Taipei Veterans General Hospital specializing in medicine, pathology, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

17

578

2

Nursing

1

1

16

3

Social Sciences

1

1

17

4

Biology

1

1

15

5

Child Development

1

1

19

Ting‐Rong Hsu

×

34

Publications

1.1K

Citations

20

H-Index

YearCitations

Later Onset Fabry Disease, Cardiac Damage Progress in Silence

Ting‐Rong Hsu, Sheng‐Che Hung, Fu‐Pang Chang,

Journal of the American College of Cardiology

2016

104

Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes

Chia-Feng Yang, Chen Yang, Hsuan-Chieh Liao,

The Journal of Pediatrics

2015

103

A large‐scale nationwide newborn screening program for pompe disease in Taiwan: Towards effective diagnosis and treatment

Chia‐Feng Yang, Hao‐Chuan Liu, Ting‐Rong Hsu,

American Journal of Medical Genetics Part A

2013

76

Change in treatment strategy for intracranial germinoma: Long‐term follow‐up experience at a single institute

Yiwei Chen, Pin‐I Huang, Donald Ming‐Tak Ho,

Cancer

2011

61

Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation

Christiane Auray‐Blais, Paméla Lavoie, Michel Boutin,

Clinica Chimica Acta

2017

52

Cognitive and epilepsy outcomes after epilepsy surgery caused by focal cortical dysplasia in children: early intervention maybe better

Hsin‐Hung Chen, Chien Chen, Sheng‐Che Hung,

Child s Nervous System

2014

50

<p>Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age</p>

Rossella Parini, Guillem Pintos‐Morell, Julia B. Hennermann,

Drug Design Development and Therapy

2020

49

Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)

Ting‐Rong Hsu, Shih-Hsien Sung, Fu-Pang Chang,

Orphanet Journal of Rare Diseases

2014

40

Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)

Hsuan-Chieh Liao, Yu-Hsiu Huang, Yann-Jang Chen,

Clinica Chimica Acta

2013

39

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)

Haochuan Liu, Hsiang-Yu Lin, Chia‐Feng Yang,

Orphanet Journal of Rare Diseases

2014

38

Page 1